- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0125306

Pharmacle Laboratory Private Limited
About Pharmacle Laboratory Private Limited
Data last updated:
Pharmacle Laboratory Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 28 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U51397MH2016PTC289053.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajay Sukhdeo Murkute and Rohit Ridheshwar Warjukar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nagpur, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹60,980, a decline of 38% compared to the previous year. For the same year it recorded a net profit of ₹1,986 (net margin 3.3%) and EBITDA of ₹3,313 (EBITDA margin 5.4%).
Pharmacle Laboratory Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0125306). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Pharmacle Laboratory
Contact details
Pharmacle Laboratory Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressGhar Kramank 190/J Block No 107, 1st Floor Jay Complex Gandhibagh, Nagpur, Maharashtra, India – 440002
- IndustryTrading, Retail Trading, Retailers
To see the full contact details of Pharmacle Laboratory Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pharmacle Laboratory is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Pharmacle Laboratory Private Limited, buy the company report.
Financials of Pharmacle Laboratory Private Limited
FY 2025 filings availablePharmacle Laboratory Private Limited reported revenue of ₹60,980 (down 38% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 38% in the latest year. EBITDA rose 449% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3,313 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,986 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharmacle Laboratory Private Limited, buy the company report.
Board of directors of Pharmacle Laboratory Private Limited
Pharmacle Laboratory has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Sukhdeo Murkute | Director | 28 Dec 2016 | 9 Years 9 Months | Current |
| Rohit Ridheshwar Warjukar Also directs: Big Buzz HRS Private Limited | Director | 15 Nov 2025 | 0 Years 11 Months | Current |
Peer comparison
Pharmacle Laboratory Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Madhu Chandra Techno-Chem Complex Pvt Ltd | ₹61,445 (FY 2024) | -100.0% | Uttar Pradesh, India | |||
| Ishom Fragrance Private Limited | ₹61,283 (FY 2024) | Jaipur, Rajasthan, India | ||||
| Saplings Biotech Private Limited | ₹61,228 (FY 2022) | Lucknow, Uttar Pradesh, India | ||||
| United Chemicals & Catalysts Private Limited | ₹61,215 (FY 2025) | 17.0% | Chennai, Tamil Nadu, India | |||
| Microbzymes Private Limited | ₹61,101 (FY 2023) | -6.0% | Ernakulam, Kerala, India | |||
| Pharmacle Laboratory Private Limitedthis company | ₹60,980 (FY 2025) | ₹1,986 | 3.3% | -38.0% | Nagpur, Maharashtra, India | |
| Sannolik Pharmaceuticals Private Limited | ₹60,500 (FY 2023) | -69.0% | Gaya, Bihar, India | |||
| Chinnamile Organic Industries Private Limited | ₹60,500 (FY 2021) | 39.0% | Hyderabad, Telangana, India | |||
| Danev Pestaid Private Limited | ₹60,340 (FY 2022) | -90.0% | Panoli, Gujarat, India | |||
| Avaskin Design Systems Private Limited | ₹60,180 (FY 2025) | Noida, Uttar Pradesh, India | ||||
| Vamika Beauty Care Private Limited | ₹60,078 (FY 2025) | 45.0% | Modasa, Gujarat, India |
To see the full peer comparison of Pharmacle Laboratory Private Limited, buy the company report.
Auditor
Pharmacle Laboratory Private Limited is audited by ABDULQUADIR&CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABDULQUADIR&CO. | FY 2017 | 127299W |
Shareholding
The shareholding of Pharmacle Laboratory Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Pharmacle Laboratory Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pharmacle Laboratory Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharmacle Laboratory Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Pharmacle Laboratory Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Pharmacle Laboratory Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Rohit Ridheshwar Warjukar was appointed as Director on 15 Nov 2025.
Frequently asked questions
Pharmacle Laboratory is an active private limited company based in Nagpur, Maharashtra, India. The company works in retail trading, within the trading industry. It was incorporated on 28 December 2016 (10+ years old) and is registered under CIN U51397MH2016PTC289053.
Pharmacle Laboratory has 2 current directors:
- Ajay Sukhdeo Murkute - Director
- Rohit Ridheshwar Warjukar - Director
The latest financial statements of Pharmacle Laboratory on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Pharmacle Laboratory is U51397MH2016PTC289053. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmacle Laboratory was incorporated on 28 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Pharmacle Laboratory by revenue are Madhu Chandra Techno-Chem Complex Pvt Ltd, Ishom Fragrance Private Limited, Saplings Biotech Private Limited, United Chemicals & Catalysts Private Limited, Microbzymes Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rohit Ridheshwar Warjukar was appointed as Director on 15 Nov 2025. Ajay Sukhdeo Murkute was appointed as Director on 28 Dec 2016. Bindiya Jitendra Murkute was appointed as Director on 28 Dec 2016.
Yes, Pharmacle Laboratory is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0125306).
The registered office of Pharmacle Laboratory is at Ghar Kramank 190J Block No 107, 1st Floor Jay Complex Gandhibagh, Nagpur, Maharashtra, India – 440002.
Pharmacle Laboratory operates in the trading industry, in the retail trading segment.
The compliance status of Pharmacle Laboratory is compliant as of 29 September 2026. The company is actively filing with the Registrar of Companies.